EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring

Stefania Federico, Suzy Williams, Richard C Wilson, Paul Arkel, Mark J Gilchrist, Alison H Holmes, Timothy M Rawson, Alaa Riezk iD

Analytical Methods · 2026

DOI: 10.1039/d6ay00331a ↗

Kurz gefasst

Fachartikel in der Zeitschrift Analytical Methods, 2026. Verfasst von Stefania Federico und 7 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Antimicrobial Optimisation, Imperial College London, London, UK. alaa.riezk@imperial.ac.uk. Hauptthemen laut MEDLINE: Meropenem, Tandem Mass Spectrometry, Piperacillin, Drug Monitoring. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Wellcome Trust, NIHR Imperial Biomedical Research Centre, National Institute for Health Research Health Protection Research Unit.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A highly sensitive LC-MS/MS method (LLOQ 0.02 mg L −1 ) enables simultaneous quantification of piperacillin, tazobactam and meropenem for therapeutic drug monitoring in critically ill patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MeropenemTandem Mass SpectrometryPiperacillinDrug MonitoringLiquid Chromatography-Mass SpectrometryAnti-Bacterial Agentsbeta-LactamsHumansTazobactamPenicillanic Acidbeta Lactam AntibioticsChromatography, LiquidThienamycinsReproducibility of ResultsLimit of Detection

Substanzen

MeropenemPiperacillinTazobactamAnti-Bacterial AgentsPenicillanic Acidbeta Lactam Antibioticsbeta-LactamsThienamycins

Autor:innen und Institutionen

  • Centre for Antimicrobial Optimisation, Imperial College London, London, UK. alaa.riezk@imperial.ac.uk.
  • Pharmacy Department, Imperial College Healthcare NHS Trust, London, UK.
  • National Institute for Health Research Health Protection Research Unit in Healthcare Associated Infections and Antimicrobial Resistance, Imperial College London, London, UK.
  • David Price Evans Infectious Diseases & Global Health Group, The University of Liverpool, Liverpool, UK.
  • OPAT Service, Imperial College Healthcare NHS Trust, London, UK.
  • Fleming Initiative, Fleming Centre, Imperial College London and Imperial College Healthcare NHS Trust, London, UK.

ORCID-Profile: Alaa Riezk

Förderung

  • Wellcome Trust
  • NIHR Imperial Biomedical Research Centre
  • National Institute for Health Research Health Protection Research Unit
  • Imperial College London
  • Public Health England
  • NIHR Sheffield Clinical Research Facility
  • Imperial College Healthcare NHS Trust

Zitieren

APA

Federico, S., Williams, S., Wilson, R. C., Arkel, P., Gilchrist, M. J., Holmes, A. H., Rawson, T. M., & Riezk, A. (2026). Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring. Analytical Methods. https://doi.org/10.1039/d6ay00331a

Vancouver

Federico S, Williams S, Wilson RC, Arkel P, Gilchrist MJ, Holmes AH, et al. Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring. Analytical Methods. 2026. doi:10.1039/d6ay00331a

BibTeX
@article{Federico2026,
  author = {Federico, Stefania and Williams, Suzy and Wilson, Richard C and Arkel, Paul and Gilchrist, Mark J and Holmes, Alison H and Rawson, Timothy M and Riezk, Alaa},
  title = {Simultaneous measurement of piperacillin, tazobactam and meropenem in patient samples using LC-MS/MS to support β-lactam therapeutic drug monitoring},
  journal = {Analytical Methods},
  year = {2026},
  doi = {10.1039/d6ay00331a}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche